Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01315119 · ClinicalTrials.gov registry record
SPY Intra-Operative Angiography & Skin Perfusion in Immediate Breast Reconstruction w/ Implants
A clinical trial, sponsored by Stanford University.
- Completed
- Registry status
- 100
- Enrollment target
NCT01315119: Completed study, sponsored by Stanford University.
NCT01315119 is a clinical trial that has completed, run by Stanford University. The registered enrollment target is 100 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01315119 has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- 100 participants
- Enrollment target
Study Summary
The investigators hope to learn the value of the SPY ELITE® intra-operative angiography in reducing post-operative complications associated with low breast skin blood flow after breast reconstruction using implants.
Interventions
- PROCEDURE SPY Intra-Operative Angiography
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2011-06 |
| Est. Completion | 2015-09-23 |
What the finished NCT01315119 record still lists
NCT01315119 is an observational study that tracks outcomes without assigning an intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which SPY Intra-Operative Angiography is the first listed.
NCT01315119 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01315119 about?
NCT01315119 is a clinical study titled "SPY Intra-Operative Angiography & Skin Perfusion in Immediate Breast Reconstruction w/ Implants". The investigators hope to learn the value of the SPY ELITE® intra-operative angiography in reducing post-operative complications associated with low breast skin blood flow after breast reconstruction using implants.
What is the current status of trial NCT01315119?
This trial is currently completed. The enrollment target is 100 participants. The study started on 2011-06. Estimated completion is 2015-09-23.
What interventions are being tested in trial NCT01315119?
The interventions under investigation include: SPY Intra-Operative Angiography (PROCEDURE).
Who is sponsoring clinical trial NCT01315119?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia